Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA)

Publication ,  Conference
Patel, YA; Gifford, E; Glass, LM; McNeil, R; Turner, MJ; Han, B; Provenzale, DT; Choi, SS; Moylan, CA; Hunt, CM
Published in: HEPATOLOGY
October 1, 2017

Duke Scholars

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2017

Volume

66

Start / End Page

1164A / 1164A

Location

Washington, DC

Publisher

WILEY

Conference Name

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Patel, Y. A., Gifford, E., Glass, L. M., McNeil, R., Turner, M. J., Han, B., … Hunt, C. M. (2017). Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA). In HEPATOLOGY (Vol. 66, pp. 1164A-1164A). Washington, DC: WILEY.
Patel, Yuval A., Elizabeth Gifford, Lisa M. Glass, Rebecca McNeil, Marsha J. Turner, Byungjoo Han, Dawn T. Provenzale, Steve S. Choi, Cynthia A. Moylan, and Christine M. Hunt. “Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA).” In HEPATOLOGY, 66:1164A-1164A. WILEY, 2017.
Patel YA, Gifford E, Glass LM, McNeil R, Turner MJ, Han B, Provenzale DT, Choi SS, Moylan CA, Hunt CM. Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA). HEPATOLOGY. WILEY; 2017. p. 1164A-1164A.
Journal cover image

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2017

Volume

66

Start / End Page

1164A / 1164A

Location

Washington, DC

Publisher

WILEY

Conference Name

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics